Table 1 Demographics and clinical scores of participants

Number

228

157

Gender

35% F: 65% M

61% F: 39% M

Age

71 (9.7)

69.6 (8.7)

Disease duration

6.0 (6.0)

n/a

Unified Parkinson’s Disease rating scale

 Part I

10.0 (8.0)

n/a

 Part II

11.0 (9.0)

n/a

 Part III (“ON”)

36.0 (18.0)

n/a

 Part IV

4.5 (6.0)

n/a

 Total

62.5 (29.3)

n/a

Levodopa Equivalent Daily Dose

675 (500)

n/a

Parkinson’s Disease Questionnaire

28 (29)

n/a

Median Dyskinesia Score

2.1 (3.7)

2.6 (2.8)

Adjusted median Dyskinesia Score

1.3 (2.5)

1.5 (2.2)

Median Bradykinesia Score

25 (9.6)

22.0 (2.8)

Active median Bradykinesia score

23.9 (7.8)

21.4 (3.2)